Literature DB >> 10227595

The use of fine-needle aspiration cytology in the molecular characterization of neuroblastoma in children.

B Fröstad1, T Martinsson, E Tani, U Falkmer, C Darnfors, L Skoog, P Kogner.   

Abstract

BACKGROUND: The utility of fine-needle aspiration (FNA) material in the molecular characterization of a group of neuroblastic tumors (NT) in children is presented.
METHODS: A recent study showed a high accuracy rate for FNA cytology (FNAC) in combination with immunostaining as a diagnostic method in 26 children with NT. In the current study FNA smears from 18 children were analyzed, either at the time of diagnosis or retrospectively, on available stored smears for cellular DNA content (DNA ploidy) by means of image cytometry (ICM) and 1p deletion and N-myc amplification by interphase fluorescent in situ hybridization (FISH).
RESULTS: A total 62 analyses (DNA ploidy, 20 analyses; chromosome 1 or 2 number, 11 analyses; 1p deletion, 16 analyses; and N-myc, 15 analyses) resulted in clear information in 60 cases, whereas 2 tests for N-myc amplification failed. The results were compared with each other and with cytometric DNA analyses on tumor touch imprints (n = 12) and N-myc analyses on material from surgical specimens (Southern blot analysis, n = 12). The results were concordant in all but seven analyses (all with clear informative results) in six children. These discrepancies may be explained as an effect of either chemotherapy or tumor heterogeneity.
CONCLUSIONS: FNA is a fast and noninvasive diagnostic technique that yields sufficient material for the molecular characterization of neuroblastic tumors by means of FISH and ICM. Such analyses are of prognostic significance because they predict tumor behavior and response to therapy according to International Neuroblastoma Staging System/International Neuroblastoma Risk Groups criteria. In the majority of cases it also is possible to obtain material for storage and future investigations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10227595

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Assessment of fine needle aspiration cytology samples for molecular genetic analysis in neuroblastoma.

Authors:  Ankur Mandelia; Sandeep Agarwala; Arundhati Sharma; Venkateswaran K Iyer; Veereshwar Bhatnagar
Journal:  Pediatr Surg Int       Date:  2013-11       Impact factor: 1.827

Review 2.  Neuroblastoma tumour genetics: clinical and biological aspects.

Authors:  N Bown
Journal:  J Clin Pathol       Date:  2001-12       Impact factor: 3.411

3.  Cytogenetic evaluation of neuroblastoma using fine needle aspiration cultures.

Authors:  G Moorthy; Sandeep Agarwala; Arundhati Sharma; Venkateshwaran K Iyer; M Srinivas; Minu Bajpai; Veereshwar Bhatnagar; Devendra K Gupta
Journal:  Pediatr Surg Int       Date:  2009-11       Impact factor: 1.827

4.  Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors.

Authors:  Hanna Kryh; Helena Carén; Jennie Erichsen; Rose-Marie Sjöberg; Jonas Abrahamsson; Per Kogner; Tommy Martinsson
Journal:  BMC Genomics       Date:  2011-09-07       Impact factor: 3.969

5.  International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.

Authors:  P F Ambros; I M Ambros; G M Brodeur; M Haber; J Khan; A Nakagawara; G Schleiermacher; F Speleman; R Spitz; W B London; S L Cohn; A D J Pearson; J M Maris
Journal:  Br J Cancer       Date:  2009-05-05       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.